Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Artia Global Partners LP
Form 13F · Q2 2026

Artia Global Partners LP

CIK 1937964Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$542M
Reported book value
48
Positions
12
Quarters on record
Top 50
Positions

Artia Global Partners LP — holdings

Top 47 positions of 48, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1ABIVAX SA Abivax Sa516,447−14.0%$69M12.7%
2INSM Insmed Inc589,052−6.3%$63M11.6%
3TRVI Trevi Therapeutics Inc2.2M+9.8%$41M7.6%
4BRIGHTSPRING HEALTH SVCS INC Brightspring Health Svcs Inc517,315+861.6%$36M6.7%
5RVMD Revolution Medicines Inc185,390+48.3%$35M6.4%
6ARGX Argenx Se29,739+0.0%$28M5.1%
7ALKS Alkermes Plc448,964—$24M4.3%
8TVTX Travere Therapeutics Inc339,033+379.5%$19M3.6%
9AZN Astrazeneca Plc98,376+3.1%$19M3.4%
10NAMS Newamsterdam Pharma Company503,936+0.0%$17M3.2%
11DNTH Dianthus Therapeutics Inc162,990+0.0%$16M2.9%
12DGX Quest Diagnostics Inc65,122+59.5%$14M2.5%
13IONS Ionis Pharmaceuticals Inc144,376+0.0%$11M2.1%
14EYPT Eyepoint Inc767,098+0.0%$11M2.0%
15ALMS Alumis Inc278,546−14.3%$8M1.4%
16VKTX Viking Therapeutics Inc180,731+0.0%$7M1.3%
17CELC Celcuity Inc59,316+280.8%$6M1.1%
18CYTK Cytokinetics Inc70,700+333.7%$6M1.1%
19MRK Merck & Co Inc46,700+0.0%$6M1.1%
20RAPP Rapport Therapeutics Inc138,508+0.0%$6M1.1%
21JNJ Johnson & Johnson22,600+0.0%$6M1.1%
22GH Guardant Health Inc38,100—$6M1.1%
23ABSI Absci Corporation464,444—$5M1.0%
24SRRK Scholar Rock Hldg Corp96,285+0.0%$5M1.0%
25SION Sionna Therapeutics Inc119,741+0.0%$5M1.0%
26ASND Ascendis Pharma A/S17,740—$5M0.9%
27ROIV Roivant Sciences Ltd129,800+0.0%$5M0.8%
28PALI Palisade Bio Inc2.0M+0.0%$4M0.8%
29EWTX Edgewise Therapeutics Inc98,800+50.8%$4M0.7%
30BIIB Biogen Inc18,437+0.0%$4M0.7%
31XENE Xenon Pharmaceuticals Inc65,000+0.0%$4M0.7%
32BLTE Belite Bio Inc24,989+0.0%$4M0.7%
33MLYS Mineralys Therapeutics Inc137,800+0.0%$4M0.7%
34PROK Prokidney Corp1.8M+0.0%$4M0.7%
35ELVN Enliven Therapeutics Inc72,100+245.0%$4M0.7%
36ORKA Oruka Therapeutics Inc33,400—$3M0.6%
37PTGX Protagonist Therapeutics Inc22,951+0.1%$3M0.5%
38UTHR United Therapeutics Corp Del5,000+0.0%$3M0.5%
39DRUG Bright Minds Biosciences Inc38,407+0.0%$3M0.5%
40KINIKSA PHARMACEUTICALS INTL Kiniksa Pharmaceuticals Intl29,200+0.0%$2M0.3%
41CMPX Compass Therapeutics Inc383,200—$839,2080.2%
42PRAX Praxis Precision Medicines I2,500+0.0%$836,9750.2%
43KOD Kodiak Sciences Inc17,019+0.0%$663,0600.1%
44TENX Tenax Therapeutics Inc42,080+0.0%$612,2640.1%
45NUVALENT INC Nuvalent Inc4,900+0.0%$605,1500.1%
46PEPG Pepgen Inc205,324+0.0%$369,5830.1%
47SYRE Spyre Therapeutics Inc4,000—$355,1200.1%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.